Additionally, in breast cancer, we found a similar up-regulation of NME1 in ductal carcinoma in situ when compared to the surrounding non-malignant tissues, whereas NME1 levels were significantly reduced in invasive tumor foci and in microinvasive carcinoma buds extending beyond the ruptured basement membrane [61]. This evidence concerns the gene NME1 and breast carcinoma.